Please assess the completion status of the following clinical trial:

Trial Title: Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients at risk of developing OHSS, defined by the development of 20-30 follicles larger than 12 mm in diameter and retrieval of more than 20 oocytes~* ovarian stimulation with long protocol~Exclusion Criteria:~* coasting cases

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: SHAM_COMPARATOR): Receive human albumin 20% infusion
- Cabergoline (Type: EXPERIMENTAL): Receive cabergoline tablet (0/5 mg) daily until 6 days after oocytes retrieval

Based on this trial design, predict the completion outcome and termination type (if applicable).